Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Related Articles by Review for PubMed (Select 21868017)

1.

Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study.

Virani SS, Catellier DJ, Pompeii LA, Nambi V, Hoogeveen RC, Wasserman BA, Coresh J, Mosley TH, Otvos JD, Sharrett AR, Boerwinkle E, Ballantyne CM.

Atherosclerosis. 2011 Dec;219(2):596-602. doi: 10.1016/j.atherosclerosis.2011.08.001. Epub 2011 Aug 7.

2.

Pitavastatin: novel effects on lipid parameters.

Chapman MJ.

Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Review.

PMID:
22152282
3.

Why is non-high-density lipoprotein cholesterol a better marker of the risk of vascular disease than low-density lipoprotein cholesterol?

Sniderman A, McQueen M, Contois J, Williams K, Furberg CD.

J Clin Lipidol. 2010 May-Jun;4(3):152-5. doi: 10.1016/j.jacl.2010.03.005. Epub 2010 Mar 18. Review.

PMID:
21122647
4.

The strengths and limitations of the apoB/apoA-I ratio to predict the risk of vascular disease: a Hegelian analysis.

Sniderman AD, Kiss RS.

Curr Atheroscler Rep. 2007 Oct;9(4):261-5. Review.

PMID:
18173952
5.

Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention.

Millán J, Pintó X, Muñoz A, Zúñiga M, Rubiés-Prat J, Pallardo LF, Masana L, Mangas A, Hernández-Mijares A, González-Santos P, Ascaso JF, Pedro-Botet J.

Vasc Health Risk Manag. 2009;5:757-65. Epub 2009 Sep 18. Review.

6.

High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review.

Amarenco P, Labreuche J, Touboul PJ.

Atherosclerosis. 2008 Feb;196(2):489-96. Epub 2007 Oct 17. Review.

PMID:
17923134
7.

Management of non-high-density lipoprotein abnormalities.

Rosenson RS.

Atherosclerosis. 2009 Dec;207(2):328-35. doi: 10.1016/j.atherosclerosis.2009.05.020. Epub 2009 May 27. Review.

PMID:
19545870
8.

Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoB.

Sniderman AD, Lamarche B, Contois JH, de Graaf J.

Curr Opin Lipidol. 2014 Dec;25(6):461-7. doi: 10.1097/MOL.0000000000000127. Review.

PMID:
25340478
9.

The apolipoprotein story.

Sacks FM.

Atheroscler Suppl. 2006 Aug;7(4):23-7. Epub 2006 Jul 5. Review.

PMID:
16822722
10.

How do elevated triglycerides and low HDL-cholesterol affect inflammation and atherothrombosis?

Welty FK.

Curr Cardiol Rep. 2013 Sep;15(9):400. doi: 10.1007/s11886-013-0400-4. Review.

11.

Cell-mediated lipoprotein transport: a novel anti-atherogenic concept.

Bovenberg SA, Alipour A, Elte JW, Rietveld AP, Janssen JW, van de Geijn GJ, Njo TN, van Mechelen R, Hervas SM, Cabezas MC.

Atheroscler Suppl. 2010 Jun;11(1):25-9. doi: 10.1016/j.atherosclerosissup.2010.04.003. Epub 2010 Apr 27. Review.

PMID:
20427243
12.

[ApoE-containing HDL and the development of atherosclerosis].

Ćwiklińska A, Strzelecki A, Kortas-Stempak B, Zdrojewski Z, Wróblewska M.

Postepy Hig Med Dosw (Online). 2015 Jan 2;69:1-9. Review. Polish.

PMID:
25589708
13.

Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?

Bag-Ozbek A, Giles JT.

Curr Allergy Asthma Rep. 2015 Feb;15(2):497. doi: 10.1007/s11882-014-0497-6. Review.

PMID:
25504261
14.

Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions.

Briley-Saebo K, Yeang C, Witztum JL, Tsimikas S.

J Cardiovasc Transl Res. 2014 Nov;7(8):719-36. doi: 10.1007/s12265-014-9590-4. Epub 2014 Oct 9. Review.

PMID:
25297940
15.

Surrogate markers in clinical trials--challenges and opportunities.

Duivenvoorden R, de Groot E, Stroes ES, Kastelein JJ.

Atherosclerosis. 2009 Sep;206(1):8-16. doi: 10.1016/j.atherosclerosis.2008.12.009. Epub 2008 Dec 14. Review.

PMID:
19327774
16.

HDL as a biomarker, potential therapeutic target, and therapy.

Navab M, Anantharamaiah GM, Reddy ST, Van Lenten BJ, Fogelman AM.

Diabetes. 2009 Dec;58(12):2711-7. doi: 10.2337/db09-0538. Review. No abstract available.

17.

Human genetics of HDL: Insight into particle metabolism and function.

Brunham LR, Hayden MR.

Prog Lipid Res. 2015 Apr;58:14-25. doi: 10.1016/j.plipres.2015.01.001. Epub 2015 Jan 16. Review.

18.

Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease.

Chang CT, Yang CY, Tsai FJ, Lin SY, Chen CJ.

Biomed Res Int. 2015;2015:164846. doi: 10.1155/2015/164846. Epub 2015 May 18. Review.

19.

Emerging risk biomarkers in cardiovascular diseases and disorders.

Upadhyay RK.

J Lipids. 2015;2015:971453. doi: 10.1155/2015/971453. Epub 2015 Apr 8. Review.

20.

The role of high-density lipoproteins in the regulation of angiogenesis.

Tan JT, Ng MK, Bursill CA.

Cardiovasc Res. 2015 May 1;106(2):184-93. doi: 10.1093/cvr/cvv104. Epub 2015 Mar 10. Review.

PMID:
25759067
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk